|
Commitments and Contingencies - Additional Information (Detail)
|
3 Months Ended | 6 Months Ended | 1 Months Ended | 6 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2014
USD ($)
|
Jun. 30, 2013
USD ($)
|
Jun. 30, 2014
USD ($)
|
Jun. 30, 2013
USD ($)
|
Jun. 30, 2014
Excess lease facility [Member]
USD ($)
|
Dec. 31, 2013
Excess lease facility [Member]
USD ($)
|
Jun. 30, 2014
Other Long Term Assets [Member]
USD ($)
|
Dec. 31, 2009
Teva Pharmaceutical Industries Ltd. [Member]
Collaboration arrangement [Member]
USD ($)
|
Jun. 30, 2014
Teva Pharmaceutical Industries Ltd. [Member]
Collaboration arrangement [Member]
USD ($)
|
Jun. 30, 2014
Isis Pharmaceuticals Inc. and University of British Columbia [Member]
USD ($)
|
Jun. 30, 2014
Isis Pharmaceuticals Inc. and University of British Columbia [Member]
Collaboration arrangement [Member]
CAD
|
Jun. 30, 2014
Isis Pharmaceuticals Inc. [Member]
Collaboration arrangement [Member]
USD ($)
|
|
| Other Commitments [Line Items] | ||||||||||||
| Collaboration agreement aggregate amount | $ 50,000,000 | |||||||||||
| Maximum amount receivable | 370,000,000 | |||||||||||
| Equity investment | 10,000,000 | |||||||||||
| Direct and indirect costs incurred | 30,000,000 | |||||||||||
| Milestone payments | 1,600,000 | 7,750,000 | ||||||||||
| Amount receivable by Isis from TEVA as a milestone payment | 30.00% | |||||||||||
| Percentage of un-spent portion to be paid | 30.00% | |||||||||||
| Obligation to pay patent costs and annual license maintenance fees | 8,000 | |||||||||||
| Milestone payment | 100,000 | 800,000 | ||||||||||
| Expiry period of agreement of patented license | 20 years | |||||||||||
| Range of each product line | 10 years | |||||||||||
| Milestone payment due | 20,000,000 | 20,000,000 | ||||||||||
| Period of milestone payment | 21 days | 21 days | ||||||||||
| Reserve for contingency of non payment of non-royalty milestone amount | 20,000,000 | 20,000,000 | ||||||||||
| Milestone payment made | 10,000,000 | 10,000,000 | ||||||||||
| Balance amount of milestone payment | 10,000,000 | 10,000,000 | ||||||||||
| Expiration of operating lease agreement | 2015-09 | |||||||||||
| Expiration of non-cancellable operating lease agreement | 2017 | |||||||||||
| Cash security deposit | 500,000 | |||||||||||
| Standby letter of credit | 300,000 | 300,000 | ||||||||||
| Lease liability | 3,523,000 | 3,906,000 | ||||||||||
| Consolidated rent and facilities expense | 700,000 | 700,000 | 1,400,000 | 1,400,000 | ||||||||
| Indemnification obligations | 0 | 0 | ||||||||||
| Expenses related to indemnification issues | $ 0 | $ 0 | ||||||||||